Page last updated: 2024-08-23

nigericin and Lymphoma, T-Cell

nigericin has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawaguchi, M; Kobayashi, Y; Watanabe, N	1

Other Studies

1 other study(ies) available for nigericin and Lymphoma, T-Cell

Article	Year
Activation of interleukin-1beta-converting enzyme by nigericin is independent of apoptosis. Cytokine, 1998, Volume: 10, Issue:9 Topics: Animals; Apoptosis; Caspase 1; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Enzyme Precursors; Humans; Interleukin-1; Ionophores; Leukemia, Monocytic, Acute; Lipopolysaccharides; Lymphoma, T-Cell; Mice; Monocytes; Nigericin; Oligopeptides; Potassium; Tumor Cells, Cultured	1998

Article

Year

Activation of interleukin-1beta-converting enzyme by nigericin is independent of apoptosis.

Cytokine, 1998, Volume: 10, Issue:9

Topics: Animals; Apoptosis; Caspase 1; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Enzyme Precursors; Humans; Interleukin-1; Ionophores; Leukemia, Monocytic, Acute; Lipopolysaccharides; Lymphoma, T-Cell; Mice; Monocytes; Nigericin; Oligopeptides; Potassium; Tumor Cells, Cultured

1998